SEC Form 4 · accession 0001209191-17-026450
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Coughlin
Director
Period of report
Apr 7, 2017
Accepted (ET)
Apr 10, 2017 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.25 | Apr 7, 2017 | A | 32,000 | A | — | Apr 7, 2027 | Common Stock | 32,000 | 32,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning May 7, 2017, such that this option will fully exercisable on April 7, 2020, subject to the recipient's continued service on the Issuer's Board of Directors.